Market Overview

JP Morgan Maintains Overweight on Rigel Pharmaceuticals, Inc., Lowers PT to $10.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for RIGL

DateFirmActionFromTo
Mar 2014JefferiesMaintainsBuy
Jun 2013JefferiesMaintainsBuy
Jun 2013JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for RIGL
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (RIGL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters